The United States Food and Drug Administration (“FDA”) cleared the sale and marketing of the type 2 diabetes drug Invokana (canagliflozin) in March of 2013. In Europe, the European Medicines Agency (also known as the “EMA”), approved Invokana for sale and marketing throughout the European Union market a few months later. Sales for Invokana grew […]
The United States Food and Drug Administration (“FDA”) cleared the sale and marketing of the type 2 diabetes drug Invokana (canagliflozin) in March of 2013. In Europe, the European Medicines Agency (also known as the “EMA”), approved Invokana for sale and marketing throughout the European Union market a few months later.
Sales for Invokana grew substantially in the years since its approval, despite the serious injuries seen during two large clinical studies in patients taking canagliflozin, and sales remain huge even after grave consumer alerts and warnings from both the U.S. Food and Drug Administration and the European Medicines Agency. In 2016, Invokana sales topped $1.4 billion worldwide. This was approximately $100 million more than the previous sales report back in 2015. In just the first nine months of 2017, Invokana sales were reported to be $844 million worldwide.
On May 6, 2017, the U.S. Food and Drug Administration (FDA) concluded that a type 2 diabetes medicine called canagliflozin, used in brand-name drugs such as Invokana, Invokamet, and Invokamet XR increased the risk of leg and foot amputations. The U.S. Food and Drug Administration also announced that new warning labels (“Boxed Warnings”) would be required on canagliflozin drug labels to explain these potential risks.
Parker Waichman LLP is representing clients who have sustained suffered serious side effects from Invokana, Invokamet and Invokamet XR resulting in leg amputations, foot amputations (partial or full amputation), and toe amputations.
In February of 2017, the (EMA) or European Medicines Agency also released a warning to the public regarding SGLT2 inhibitors. This additional governmental warning states the same “lower limb” amputation warnings given by the FDA, and warns that other SGLT2 inhibitors could also increase the risk for toe amputations.
The SGLT2 inhibitor medications identified by the EMA are:
Time is limited to file your Invokana claim so that you may receive the monetary compensation you are legally owed. Each state has unique deadlines for submitting a claim called “Statutes of Limitations.” If you or your loved one were prescribed a type 2 diabetes drugs such as Invokana, Invokamet or Invokamet XR and you sustained amputation of the leg, foot or toe, it is imperative that you have your Invokana amputation case reviewed by a qualified Invokana amputation lawsuit attorney.
Whether your interest is to recover a monetary award for your injuries or to hold Janssen Pharmaceuticals accountable for their negligent manufacturing and marketing practices, you have the power to make a difference and help protect the public.
What Types of Damages or Compensation Should I Seek?
Parker Waichman LLP understands how your Invokana amputation has affected your life, and our legal professionals are devoted to helping you recover full compensation. Our lawyers will prepare and file your Invokana claim for damages against Janssen Pharmaceuticals and Johnson & Johnson. Our attorneys have great experience in seeking to ensure that our clients recover damages for all of the ways in which their medications have harmed them.
When you retain Parker Waichman LLP, our attorneys will help you calculate your complete economic and non-economic damages. This will maximize the amount you and your family can receive. Our law firm understands that you need full compensation. Our caring and dedicated legal team will work tirelessly with the goal of making that happen in your case.
Filing an Invokana amputation lawsuit against major drug manufacturers such as Janssen and Johnson & Johnson is an extremely involved and high-priced legal process. Also, you only have one opportunity to recover the full monetary compensation that you are entitled. There are no “do-overs” should you lose your case. Therefore, retaining a qualified and seasoned Invokana lawyer who has both the experience and resources to prosecute your case in the manner it deserves is critical for a full, financial recovery.
The primary case process of filing an Invokana Amputation Lawsuit is as follows:
Parker Waichman LLP always strives to keep our clients well informed and comfortable throughout the progress of their Invokana case. At Parker Waichman LLP, you are treated with respect, compassion, and dignity. Our legal professionals understand that you are a person with real injuries and a painful story, and that you need a timely resolution.
Parker Waichman, LLP has been directly involved in with the current Invokana amputation litigation. In fact, Parker Waichman LLP appeared in national headlines on January 2, 2018, because our attorneys filed two very important and significant Invokana amputation lawsuits.
The lawyers at Parker Waichman LLP also have an extensive background and courtroom success in complex products liability litigation. Our law firm has achieved significant jury awards, settlements, and verdicts in numerous complex drug liability proceedings against powerful pharmaceutical companies.
We encourage you to visit our Client Testimonials and Verdicts and Settlements pages for more information.
Our law firm will be fiercely dedicated to your case, and we will protect your legal right to receive just compensation. For your free case review, call 1-800-YOURLAWYER (1-800-968-7529) or use our contact form.
For additional information about SGLT2 drugs, visit our Invokana Lawsuits page.
